Nymox Pharmaceutical (PK)【NYMXF】銘柄情報

Nymox Pharmaceutical Corp (PK) (NYMXF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.12

( - )

買値

0.0902

売値

0.1399

出来高

平均取引量 (3 か月)

US$ 41,142

財務取引量

0.00 日の範囲 0.00

0.03 52 週間の範囲 0.1999

時価総額

12.245M

企業価値

15.457M

前日終値

0.12

始値

時刻

最終取引時間

VWAP

歳入

純利益

-4.49M

発行済株式数

102,040,140

浮動株比率 (%)

58.14%

機関投資家保有比率 (%)

0.03%

配当利回り

PER

-2.5

株価売上高倍率 (PSR)

1 株当たり利益 (EPS)

-0.05

ベータ

13.25

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well a... Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment and prevention of Alzheimer’s disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas. 詳細を表示

セクター

業界

ウェブサイト

nymox.com

本社

Nassau, Bahamas

設立

1989

Nymox Pharmaceutical Corp (PK) is listed in the sector of the その他OTC with ticker NYMXF. The last closing price for Nymox Pharmaceutical (PK) was US$0.12. Over the last year, Nymox Pharmaceutical (PK) shares have traded in a share price range of US$ 0.03 to US$ 0.1999.

Nymox Pharmaceutical (PK) currently has 102,040,140 shares in issue. The market capitalisation of Nymox Pharmaceutical (PK) is US$12.24 million. Nymox Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of -2.50.

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean

IRVINE, CA / ACCESS Newswire / June 17, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) is...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.12	0.1444	0.12	2117	0.12195819	CS
4	0.023	23.7113402062	0.097	0.1495	0.082	40675	0.10577505	CS
12	0.07	140	0.05	0.1999	0.0329	42166	0.08876279	CS
26	0.02565	27.186009539	0.09435	0.1999	0.03	28324	0.08141636	CS
52	0.0003	0.250626566416	0.1197	0.1999	0.03	29745	0.07451653	CS
156	-0.1411	-54.0405974722	0.2611	1.4	0.0001	32958	0.43409136	CS
260	0	0	0.12	1.4	0.0001	33690	0.43376509	CS